Index of /wp-content/uploads/2024/02

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]01-Feb-2021-HTAC-Evaluation-Framework-for-COVID-19-Vaccines.docx-4.pdf2024-02-29 14:04 181K 
[ ]06-12-Nov-2021-Weekly-Evidence-Report.pdf2024-02-28 08:28 490K 
[IMG]4th-Dose-Banner-1-150x150.png2024-02-26 15:55 17K 
[IMG]4th-Dose-Banner-1-300x114.png2024-02-26 15:55 26K 
[IMG]4th-Dose-Banner-1-500x191.png2024-02-26 15:55 55K 
[IMG]4th-Dose-Banner-1-768x293.png2024-02-26 15:55 100K 
[IMG]4th-Dose-Banner-1-1024x390.png2024-02-26 15:55 143K 
[IMG]4th-Dose-Banner-1-1536x585.png2024-02-26 15:55 241K 
[IMG]4th-Dose-Banner-1-2048x781.png2024-02-26 15:55 347K 
[IMG]4th-Dose-Banner-1.png2024-02-26 15:55 1.0M 
[IMG]20221020_131933-1-2048x1536-1-150x150.jpg2024-02-13 15:58 7.7K 
[IMG]20221020_131933-1-2048x1536-1-300x225.jpg2024-02-13 15:58 18K 
[IMG]20221020_131933-1-2048x1536-1-500x375.jpg2024-02-13 15:58 41K 
[IMG]20221020_131933-1-2048x1536-1-768x576.jpg2024-02-13 15:58 81K 
[IMG]20221020_131933-1-2048x1536-1-1024x768.jpg2024-02-13 15:58 133K 
[IMG]20221020_131933-1-2048x1536-1-1536x1152.jpg2024-02-13 15:58 247K 
[IMG]20221020_131933-1-2048x1536-1.jpg2024-02-13 15:58 409K 
[ ]ANNEX-A_Guidance-Document-on-RATs_01-August-2020.pdf2024-02-27 13:08 581K 
[ ]Advisory-Announcement-on-the-Call-for-Nominations-for-2023-17-Feb-2023.docx.pdf2024-02-29 10:26 204K 
[ ]Advisory-Consultative-Meeting-for-Administrative-Order-2020-0041.pdf2024-02-29 13:21 639K 
[ ]Advisory-Dapagliflozin-PNF-Inclusion-for-T2DM-Patients.docx-3.pdf2024-02-28 11:06 130K 
[ ]Advisory-HTAC-Preliminary-Recommendation-on-Insulin-Glargine-and-Insulin-Detemir-for-T1DM-and-T2DM.docx.pdf2024-02-22 16:00 501K 
[ ]Advisory-Stakeholder-engagement-following-the-transfer-of-the-HTA-implementation-from-the-DOH-to-the-DOST-March-2023.pdf2024-02-28 10:59 464K 
[ ]Advisory-Topic-Nomination-and-Prio-Guidelines-PubCon-28-July-2023.docx-1.pdf2024-02-28 10:30 253K 
[ ]Advisory_-Preliminary-Recommendation-on-Eribulin-mSTS.pdf2024-02-22 16:07 744K 
[ ]Advisory_-Preliminary-Recommendation-on-Pertuzumab-for-HER2-breast-cancer.pdf2024-02-22 13:49 262K 
[ ]Advisory_-Preliminary-Recommendation-on-Rituximab-for-non-Hodgkins-Lymphoma.pdf2024-02-22 14:52 500K 
[IMG]Annabelle-150x150.png2024-02-06 11:35 40K 
[IMG]Annabelle.png2024-02-06 11:35 126K 
[ ]Annex-A-Evidence-Summary-on-Pazopanib-for-mSTS.docx-1.pdf2024-02-27 11:17 252K 
[ ]Annex-A_Rapid-Review-on-ECMO-10-September-2020.pdf2024-02-27 13:03 2.4M 
[ ]Annex-B_-Rapid-Review-on-RATs_27-July-2020.pdf2024-02-27 13:08 5.7M 
[ ]Annex-B_Evidence-Summary-on-ECMO-10-September-2020.pdf2024-02-27 13:03 306K 
[ ]Annex-C_-Evidence-Summary-V2HTAC_01-August-2020.pdf2024-02-27 13:08 226K 
[ ]Annex-second-booster-for-the-individuals-ages-18-to-49-years-without-comorbidities.pdf2024-02-29 10:39 168K 
[IMG]C19-Drugs-Banner-150x150.png2024-02-26 16:32 11K 
[IMG]C19-Drugs-Banner-300x108.png2024-02-26 16:32 17K 
[IMG]C19-Drugs-Banner-500x180.png2024-02-26 16:32 36K 
[IMG]C19-Drugs-Banner-768x277.png2024-02-26 16:32 58K 
[IMG]C19-Drugs-Banner-1024x369.png2024-02-26 16:32 84K 
[IMG]C19-Drugs-Banner.png2024-02-26 16:32 54K 
[ ]CORESIA-Vaccine-Certificate-Survey-for-Key-Stakeholders.pdf2024-02-29 11:16 2.5M 
[IMG]Covovax_GenPop_Cover-150x150.png2024-02-29 13:12 32K 
[IMG]Covovax_GenPop_Cover-300x114.png2024-02-29 13:12 49K 
[IMG]Covovax_GenPop_Cover-500x191.png2024-02-29 13:12 131K 
[IMG]Covovax_GenPop_Cover-768x293.png2024-02-29 13:12 299K 
[IMG]Covovax_GenPop_Cover-1024x390.png2024-02-29 13:12 523K 
[IMG]Covovax_GenPop_Cover-1536x585.png2024-02-29 13:12 1.1M 
[IMG]Covovax_GenPop_Cover-2048x781.png2024-02-29 13:12 2.0M 
[IMG]Covovax_GenPop_Cover.png2024-02-29 13:12 9.9M 
[ ]Cycloferon_Evidence-Summary.pdf2024-02-27 13:37 88K 
[ ]DC-2021-0468-HTAC-Recommendations-on-Pediatric-Vaccination.pdf2024-02-29 09:31 1.3M 
[ ]DC-2021-0471.pdf2024-02-29 11:28 1.1M 
[ ]DC-2022-0593-Inclusion-of-Remdesivir-for-Adult-in-the-PNF.pdf2024-02-29 10:51 47M 
[ ]DC-No.-2021-0075.pdf2024-02-29 11:04 1.0M 
[ ]DC-No.-2021-0273.pdf2024-02-29 10:22 727K 
[ ]DC-No.-2021-0331.pdf2024-02-29 10:28 721K 
[ ]DC-No.-2021-0337-1.pdf2024-02-29 10:29 697K 
[ ]DC-No.-2021-0376.pdf2024-02-29 11:08 1.2M 
[ ]DC-No.-2023-0060-Epoetin-Alfa.pdf2024-02-28 10:51 6.5M 
[ ]DC-No.-2023-0061-Filgrastim.pdf2024-02-28 10:56 5.5M 
[ ]DC_2021-0410_Inclusion_of_Two-Dose_Inactivated_Polio_Vaccine_in_the_PNF.pdf2024-02-29 10:26 3.5M 
[ ]DC_NO._2021-0400_TLD-PNF-INclusion.pdf2024-02-29 10:42 1.0M 
[ ]DC_NO._2021-0423_INCLUSION_OF_DOLUTEGRAVIR_DTG_IN_THE_PHILIPPINE_NATIONAL_FORMULARY_PNF.pdf2024-02-29 13:51 1.4M 
[ ]DM-2021-0242-DM-on-the-inclusion-of-NRT-and-Varenicline-in-the-Primary-Care-Formulary.pdf2024-02-29 10:48 3.2M 
[ ]DM-No.-2021-0097.pdf2024-02-29 10:58 950K 
[ ]DM-No.-2021-0264.pdf2024-02-29 09:57 573K 
[ ]DM-No.-2021-0294-Non-inclusion-of-Lapatinib-in-the-PNF.pdf2024-02-29 10:43 666K 
[ ]DM-No.-2021-0317-NON-INCLUSION-OF-PAZOPANIB-AS-A-SECOND-LINE-TREATMENT-FOR-METASTATIC-SOFT-TISSUE-SARCOMA-mSTS-IN-THE-PHILIPPINE-NATIONAL-FORMULARY.pdf2024-02-29 09:45 1.1M 
[ ]DM-No.-2021-0367-Dtrak-104563-HEALTH-TECHNOLOGY-ASSESSMENT-COUNCILS-HTAC-UPDATED-RECOMMENDATIONS-ON-COVID-19-VACCINE-SINOVAC.pdf2024-02-29 10:41 574K 
[ ]DM-No.2021-0227.pdf2024-02-29 10:51 591K 
[ ]DOH-Department-Circular-Submission-of-Data-of-COVID-19-Vaccines-under-EUA.pdf2024-02-29 14:06 133K 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA-150x150.png2024-02-13 15:56 18K 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA-300x116.png2024-02-13 15:56 46K 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA-500x194.png2024-02-13 15:56 102K 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA-768x298.png2024-02-13 15:56 205K 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA-1024x397.png2024-02-13 15:56 329K 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA-1536x595.png2024-02-13 15:56 642K 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA-2048x794.png2024-02-13 15:56 1.0M 
[IMG]DOH-Releases-New-Implementing-Guidelines-on-HTA.png2024-02-13 15:56 2.4M 
[ ]DRAFT-DM-METHODS-FOR-SELECTION-OF-MEDICAL-DEVICES-FOR-PEMDL.pdf2024-02-28 13:28 219K 
[ ]DRAFT-PEMDL-2022.pdf2024-02-28 13:28 1.3M 
[ ]Department-Circular-No.-2021-0079-HTAC-Recommendations-on-Health-Technologies-Requiring-Full-CPR-from-the-FDA-1-1.pdf2024-02-29 11:00 655K 
[ ]Department-Circular-No.-2021-0079-HTAC-Recommendations-on-Health-Technologies-Requiring-Full-CPR-from-the-FDA-1.pdf2024-02-29 09:56 655K 
[ ]Department-Memorandum-No.-2020-0366-Inclusion-of-10-and-13-valent-Pneumococcal-Conjugate-Vaccines-PCV-multidose-preparation-in-the-Philippine-National-Formulary.pdf2024-02-29 11:05 130K 
[ ]Department-Memorandum-No.-2021-0079-Endorsement-of-Topic-Submissions-from-National-Health-Programs-for-HTA-2.pdf2024-02-29 11:01 518K 
[IMG]Dr.-Calimag--150x150.png2024-02-06 13:49 54K 
[IMG]Dr.-Calimag-.png2024-02-06 13:49 180K 
[IMG]Dr.-Cayad-an-150x150.png2024-02-06 11:35 37K 
[IMG]Dr.-Cayad-an.png2024-02-06 11:35 115K 
[IMG]Dr.-Delos-Santos-150x150.png2024-02-06 11:35 36K 
[IMG]Dr.-Delos-Santos.png2024-02-06 11:35 114K 
[IMG]Dr.-Mantaring-150x150.png2024-02-06 13:50 34K 
[IMG]Dr.-Mantaring.png2024-02-06 13:50 105K 
[IMG]Dr.-Rogado-150x150.png2024-02-06 11:35 36K 
[IMG]Dr.-Rogado.png2024-02-06 11:35 117K 
[IMG]Dr.-Tan-150x150.png2024-02-06 11:35 34K 
[IMG]Dr.-Tan.png2024-02-06 11:35 104K 
[ ]Dtrak-47419-DM-No.2021-0199.pdf2024-02-29 10:55 1.2M 
[ ]ES-Covovax.pdf2024-02-27 08:27 435K 
[ ]ES-Pfizer-Pedia-5-to-11-yo-SOH-Approved-03-Feb-2022-.pdf2024-02-26 16:20 1.1M 
[ ]ES_Huawei-Cloud-AI-Assisted-Diagnosis-for-COVID-19.pdf2024-02-27 13:30 147K 
[ ]ES_Moderna-Primary-Series-for-6-to-11-yo.pdf2024-02-29 10:32 1.0M 
[ ]ES_Oral-PrEP-for-HIV_as-of-Nov-2021.docx-1.pdf2024-02-26 16:34 698K 
[IMG]Eribulin-recommendation-150x150.jpg2024-02-26 10:08 8.4K 
[IMG]Eribulin-recommendation-300x272.jpg2024-02-26 10:08 27K 
[IMG]Eribulin-recommendation-500x454.jpg2024-02-26 10:08 72K 
[IMG]Eribulin-recommendation.jpg2024-02-26 10:08 119K 
[IMG]Events-and-Press-Releases-150x150.png2024-02-07 08:40 16K 
[IMG]Events-and-Press-Releases.png2024-02-07 08:40 22K 
[ ]Evidence-Summary-as-of-04-March-2022-Rituximab-SC-for-non-Hodgkins-lymphoma.pdf2024-02-22 13:52 794K 
[ ]Evidence-Summary-on-Booster-and-Additional-Dose-Vaccination-for-the-prevention-of-COVID-19-as-of-03-November-2021.pdf2024-02-27 08:52 1.6M 
[ ]Evidence-Summary-on-Janssen-COVID-19-Vaccine-30-April-2021.pdf2024-02-27 11:01 647K 
[ ]Evidence-Summary-on-Janssen-COVID-19-Vaccine-Recommendation.pdf2024-02-27 11:01 158K 
[ ]Evidence-Summary-on-Zoledronic-Acid-07-Sept-2022.pdf2024-02-28 15:11 626K 
[ ]Evidence-Summary_AMTI-uAI-Discover-PNA_April-72020.pdf2024-02-27 13:28 180K 
[ ]Evidence_Summary_RT-PCR_Testing_for_COVID-19.pdf2024-02-27 11:10 1.2M 
[ ]Favipiravir_Evidence-Summary.pdf2024-02-27 13:33 92K 
[ ]Final-Advisory-Cerebrolysin-for-non-PNF-Inclusion-for-stroke.docx.pdf2024-02-28 10:46 150K 
[ ]Final-Advisory-DOACs-PNF-Inclusion.docx.pdf2024-02-28 10:42 146K 
[ ]For-posting-DM.-NO.-2021-0252-Health-Technology-Assessment-Councils-HTAC-Recommendations_on-RT-PCR-and-Rapid-Antigen-Testing-for-COVID-19.pdf2024-02-29 10:47 1.7M 
[ ]For-stakeholder-consultation-ES-Eribulin-for-mSTS-as-of-13-June-2022.pdf2024-02-22 13:29 332K 
[ ]For-stakeholder-consultation-Evidence-Summary-on-Insulin-Glargine-and-Insulin-Detemir-for-T1DM-and-T2DM.docx.pdf2024-02-22 13:39 767K 
[IMG]HCP_Sinovac-Banner-150x150.png2024-02-29 17:44 9.9K 
[IMG]HCP_Sinovac-Banner-300x116.png2024-02-29 17:44 18K 
[IMG]HCP_Sinovac-Banner-500x193.png2024-02-29 17:44 37K 
[IMG]HCP_Sinovac-Banner-768x297.png2024-02-29 17:44 64K 
[IMG]HCP_Sinovac-Banner-1024x395.png2024-02-29 17:44 89K 
[IMG]HCP_Sinovac-Banner-1536x593.png2024-02-29 17:44 145K 
[IMG]HCP_Sinovac-Banner-2048x791.png2024-02-29 17:44 207K 
[IMG]HCP_Sinovac-Banner.png2024-02-29 17:44 306K 
[ ]HTA-Philippines-2019-Annual-Report.pdf2024-02-07 10:05 1.8M 
[ ]HTA-Philippines-2020-Annual-Report.pdf2024-02-07 10:08 1.6M 
[ ]HTA-Philippines-2021-Annual-Report-.pdf2024-02-07 10:11 3.7M 
[ ]HTA-Philippines-Social-Values-Guide-2022.pdf2024-02-07 09:07 6.5M 
[IMG]HTA-Research-agenda-2021-150x150.png2024-02-13 15:57 15K 
[IMG]HTA-Research-agenda-2021-300x108.png2024-02-13 15:57 18K 
[IMG]HTA-Research-agenda-2021-500x180.png2024-02-13 15:57 34K 
[IMG]HTA-Research-agenda-2021-768x277.png2024-02-13 15:57 53K 
[IMG]HTA-Research-agenda-2021-1024x369.png2024-02-13 15:57 77K 
[IMG]HTA-Research-agenda-2021.png2024-02-13 15:57 51K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-1.pdf2024-02-23 16:40 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-2.pdf2024-02-27 09:07 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-3.pdf2024-02-27 09:08 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-4.pdf2024-02-27 09:11 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-5.pdf2024-02-27 09:15 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-6.pdf2024-02-27 09:25 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-7.pdf2024-02-27 09:30 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-8.pdf2024-02-27 09:34 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-9.pdf2024-02-27 09:37 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-10.pdf2024-02-27 09:42 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-11.pdf2024-02-27 09:46 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-12.pdf2024-02-27 09:49 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-13.pdf2024-02-27 09:51 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-14.pdf2024-02-27 09:54 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-15.pdf2024-02-27 09:57 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-16.pdf2024-02-27 10:00 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-17.pdf2024-02-27 10:04 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-18.pdf2024-02-27 10:08 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-19.pdf2024-02-27 10:11 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-20.pdf2024-02-27 10:13 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-21.pdf2024-02-27 10:18 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-22.pdf2024-02-27 10:21 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-23.pdf2024-02-27 10:25 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-24.pdf2024-02-27 10:30 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-25.pdf2024-02-27 10:33 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-26.pdf2024-02-27 10:40 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-27.pdf2024-02-27 10:42 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-28.pdf2024-02-27 10:46 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-29.pdf2024-02-27 10:48 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-30.pdf2024-02-27 10:51 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-31.pdf2024-02-27 10:54 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-32.pdf2024-02-27 10:56 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-33.pdf2024-02-27 11:19 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-34.pdf2024-02-27 11:22 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-35.pdf2024-02-27 11:24 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-36.pdf2024-02-27 11:26 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-37.pdf2024-02-27 11:29 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-38.pdf2024-02-27 11:31 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-39.pdf2024-02-27 11:33 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-40.pdf2024-02-27 11:36 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-41.pdf2024-02-27 11:39 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-42.pdf2024-02-27 11:41 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-43.pdf2024-02-27 11:44 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-44.pdf2024-02-27 11:46 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-45.pdf2024-02-27 11:49 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-46.pdf2024-02-27 11:51 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021-47.pdf2024-02-27 11:53 868K 
[ ]HTA-Weekly-Evidence-Report-01-08-January-2021.pdf2024-02-23 16:18 868K 
[ ]HTA-Weekly-Evidence-Report-01-to-07-July-2022.pdf2024-02-27 08:28 469K 
[ ]HTA-Weekly-Evidence-Report-01-to-07-May-2021.pdf2024-02-28 09:50 428K 
[ ]HTA-Weekly-Evidence-Report-02-to-06-May-2022.pdf2024-02-27 09:11 498K 
[ ]HTA-Weekly-Evidence-Report-02-to-08-October-2021.pdf2024-02-28 08:37 457K 
[ ]HTA-Weekly-Evidence-Report-03-to-09-September-2022-1.pdf2024-02-23 15:42 493K 
[ ]HTA-Weekly-Evidence-Report-03-to-09-September-2022.pdf2024-02-23 15:27 493K 
[ ]HTA-Weekly-Evidence-Report-04-to-10-April-2022.pdf2024-02-27 09:29 452K 
[ ]HTA-Weekly-Evidence-Report-04-to-10-December-2021.pdf2024-02-28 08:19 523K 
[ ]HTA-Weekly-Evidence-Report-04-to-10-June-2022.pdf.pdf2024-02-27 08:59 523K 
[ ]HTA-Weekly-Evidence-Report-04-to-10-September-2021.pdf2024-02-28 08:56 472K 
[ ]HTA-Weekly-Evidence-Report-05-to-09-July-2021.pdf2024-02-28 09:34 428K 
[ ]HTA-Weekly-Evidence-Report-06-to-12-August-2022.pdf2024-02-23 16:51 500K 
[ ]HTA-Weekly-Evidence-Report-06-to-12-March-2021.pdf2024-02-27 11:53 442K 
[ ]HTA-Weekly-Evidence-Report-07-13-November-2020.pdf2024-02-27 10:55 447K 
[ ]HTA-Weekly-Evidence-Report-07-to-13-August-2021-1.pdf2024-02-28 09:14 507K 
[ ]HTA-Weekly-Evidence-Report-07-to-13-February-2022.pdf2024-02-27 09:53 449K 
[ ]HTA-Weekly-Evidence-Report-07-to-14-March-2022.pdf2024-02-29 08:38 455K 
[ ]HTA-Weekly-Evidence-Report-08-to-14-July-2022.pdf2024-02-27 08:22 473K 
[ ]HTA-Weekly-Evidence-Report-08-to-14-May-2021.pdf2024-02-28 09:49 435K 
[ ]HTA-Weekly-Evidence-Report-09-to-13-May-2022.pdf2024-02-27 09:09 534K 
[ ]HTA-Weekly-Evidence-Report-09-to-15-October-2021.pdf2024-02-28 08:35 468K 
[ ]HTA-Weekly-Evidence-Report-09-to-16-Apri-2021.pdf2024-02-28 10:00 441K 
[ ]HTA-Weekly-Evidence-Report-2-to-7-January-2022.pdf2024-02-27 10:10 452K 
[ ]HTA-Weekly-Evidence-Report-4-to-12-February-2021-1.pdf2024-02-28 09:22 891K 
[ ]HTA-Weekly-Evidence-Report-4-to-12-February-2021.pdf2024-02-28 09:14 891K 
[ ]HTA-Weekly-Evidence-Report-5-to-11-Dec-2020.pdf2024-02-27 10:48 449K 
[ ]HTA-Weekly-Evidence-Report-9-to-15-January-2021-1.pdf2024-02-28 08:56 897K 
[ ]HTA-Weekly-Evidence-Report-9-to-15-January-2021-2.pdf2024-02-28 09:07 897K 
[ ]HTA-Weekly-Evidence-Report-9-to-15-January-2021.pdf2024-02-28 08:53 897K 
[ ]HTA-Weekly-Evidence-Report-10-to-16-January-2022.pdf2024-02-27 10:08 481K 
[ ]HTA-Weekly-Evidence-Report-10-to-16-July-2021.pdf2024-02-28 09:29 432K 
[ ]HTA-Weekly-Evidence-Report-11-to-17-April-2022-1.pdf2024-02-27 09:27 459K 
[ ]HTA-Weekly-Evidence-Report-11-to-17-April-2022.pdf2024-02-27 09:26 459K 
[ ]HTA-Weekly-Evidence-Report-11-to-17-June-2022.pdf.pdf2024-02-27 08:57 540K 
[ ]HTA-Weekly-Evidence-Report-11-to-17-September-2021.pdf2024-02-28 08:55 456K 
[ ]HTA-Weekly-Evidence-Report-12-to-18-Dec-2020.pdf2024-02-27 10:47 458K 
[ ]HTA-Weekly-Evidence-Report-12-to-18-June-2021.pdf2024-02-28 09:40 439K 
[ ]HTA-Weekly-Evidence-Report-13-to-17-December-2021.pdf2024-02-28 08:16 488K 
[ ]HTA-Weekly-Evidence-Report-13-to-19-August-2022.pdf2024-02-23 16:36 462K 
[ ]HTA-Weekly-Evidence-Report-13-to-19-February-2021.pdf2024-02-28 09:22 434K 
[ ]HTA-Weekly-Evidence-Report-13-to-19-March-2021.pdf2024-02-27 11:54 436K 
[ ]HTA-Weekly-Evidence-Report-13-to-19-November-2021.pdf2024-02-28 08:24 463K 
[ ]HTA-Weekly-Evidence-Report-14-20-November-2020.pdf2024-02-27 10:53 467K 
[ ]HTA-Weekly-Evidence-Report-14-to-20-August-2021.pdf2024-02-28 09:12 497K 
[ ]HTA-Weekly-Evidence-Report-14-to-20-February-2022.pdf2024-02-27 09:51 473K 
[ ]HTA-Weekly-Evidence-Report-14-to-20-March-2022-2.pdf2024-02-27 09:36 482K 
[ ]HTA-Weekly-Evidence-Report-14-to-20-March-2022.pdf2024-02-27 08:13 482K 
[ ]HTA-Weekly-Evidence-Report-15-to-21-July-2022.pdf2024-02-27 08:16 474K 
[ ]HTA-Weekly-Evidence-Report-15-to-21-May-2021.pdf2024-02-28 09:47 436K 
[ ]HTA-Weekly-Evidence-Report-16-to-20-May-2022-1.pdf2024-02-27 09:08 486K 
[ ]HTA-Weekly-Evidence-Report-16-to-20-May-2022.pdf2024-02-27 09:06 486K 
[ ]HTA-Weekly-Evidence-Report-16-to-22-January-2021.pdf2024-02-28 08:57 917K 
[ ]HTA-Weekly-Evidence-Report-16-to-22-October-2021.pdf2024-02-28 08:34 497K 
[ ]HTA-Weekly-Evidence-Report-17-to-23-April-2021.pdf2024-02-28 09:59 432K 
[ ]HTA-Weekly-Evidence-Report-17-to-23-January-2022.pdf2024-02-27 10:05 477K 
[ ]HTA-Weekly-Evidence-Report-17-to-23-July-2021.pdf2024-02-28 09:25 425K 
[ ]HTA-Weekly-Evidence-Report-18-September-to-24-September-2021.pdf2024-02-28 08:45 485K 
[ ]HTA-Weekly-Evidence-Report-18-to-24-April-2022.pdf2024-02-27 09:22 469K 
[ ]HTA-Weekly-Evidence-Report-18-to-24-June-2022.pdf2024-02-27 08:53 501K 
[ ]HTA-Weekly-Evidence-Report-19-to-25-June-2021.pdf2024-02-28 09:38 437K 
[ ]HTA-Weekly-Evidence-Report-19-to-29-Dec-2020-1.pdf2024-02-27 10:45 443K 
[ ]HTA-Weekly-Evidence-Report-19-to-29-Dec-2020.pdf2024-02-27 10:42 443K 
[ ]HTA-Weekly-Evidence-Report-20-December-to-31-December-2021.pdf2024-02-27 10:12 479K 
[ ]HTA-Weekly-Evidence-Report-20-February-to-06-March-2022.pdf2024-02-27 09:48 492K 
[ ]HTA-Weekly-Evidence-Report-20-to-26-August-2022.pdf2024-02-23 16:19 516K 
[ ]HTA-Weekly-Evidence-Report-20-to-26-February-2021.pdf2024-02-27 11:49 438K 
[ ]HTA-Weekly-Evidence-Report-20-to-26-March-2021.pdf2024-02-28 09:57 435K 
[ ]HTA-Weekly-Evidence-Report-20-to-26-November-2021.pdf2024-02-28 08:23 455K 
[ ]HTA-Weekly-Evidence-Report-21-27-Nov-2020.pdf2024-02-27 10:51 965K 
[ ]HTA-Weekly-Evidence-Report-21-to-27-August-2021.pdf2024-02-28 09:08 456K 
[ ]HTA-Weekly-Evidence-Report-21-to-27-February-2022.pdf2024-02-27 09:50 460K 
[ ]HTA-Weekly-Evidence-Report-21-to-27-March-2022.pdf2024-02-27 09:34 451K 
[ ]HTA-Weekly-Evidence-Report-21-to-27-May-2022.pdf2024-02-27 09:02 476K 
[ ]HTA-Weekly-Evidence-Report-23-to-29-January-2021.pdf2024-02-28 09:03 915K 
[ ]HTA-Weekly-Evidence-Report-23-to-29-October-2021-1.pdf2024-02-28 08:32 463K 
[ ]HTA-Weekly-Evidence-Report-24-to-30-April-2021.pdf2024-02-28 09:58 442K 
[ ]HTA-Weekly-Evidence-Report-24-to-30-January-2022.pdf2024-02-27 09:57 474K 
[ ]HTA-Weekly-Evidence-Report-24-to-30-July-2021.pdf2024-02-28 09:19 462K 
[ ]HTA-Weekly-Evidence-Report-24-to-30-June-2022.pdf2024-02-27 08:32 518K 
[ ]HTA-Weekly-Evidence-Report-25-April-to-01-May-2022.pdf2024-02-27 09:14 495K 
[ ]HTA-Weekly-Evidence-Report-25-September-to-01-October-2021.pdf2024-02-28 08:42 480K 
[ ]HTA-Weekly-Evidence-Report-26-June-to-02-July-2021.pdf2024-02-27 11:43 439K 
[ ]HTA-Weekly-Evidence-Report-27-August-to-02-September-2022.pdf2024-02-23 16:06 473K 
[ ]HTA-Weekly-Evidence-Report-27-February-to-05-March-2021.pdf2024-02-27 11:51 432K 
[ ]HTA-Weekly-Evidence-Report-27-March-to-08-Apri-l2021.pdf2024-02-28 10:00 432K 
[ ]HTA-Weekly-Evidence-Report-27-November-to-03-December-2021.pdf2024-02-28 08:20 474K 
[ ]HTA-Weekly-Evidence-Report-28-August-to-03-Septeber-2021.pdf2024-02-28 08:15 453K 
[ ]HTA-Weekly-Evidence-Report-28-March-to-03-April-2022.pdf2024-02-27 09:32 459K 
[ ]HTA-Weekly-Evidence-Report-28-May-to-03-June-2022.pdf2024-02-27 09:00 492K 
[ ]HTA-Weekly-Evidence-Report-28-Nov-04-Dec-2020.pdf2024-02-27 10:50 440K 
[ ]HTA-Weekly-Evidence-Report-29-May-to-04-June-2021.pdf2024-02-28 09:45 436K 
[ ]HTA-Weekly-Evidence-Report-30-January-to-03-February-2021-1.pdf2024-02-28 09:13 903K 
[ ]HTA-Weekly-Evidence-Report-30-January-to-03-February-2021.pdf2024-02-28 09:09 903K 
[ ]HTA-Weekly-Evidence-Report-30-July-to-05-August-2022.pdf2024-02-23 16:56 468K 
[ ]HTA-Weekly-Evidence-Report-30-October-to-05-November-2021.pdf2024-02-28 08:30 481K 
[ ]HTA-Weekly-Evidence-Report-31-January-to-6-February-2022.pdf2024-02-27 09:55 495K 
[ ]HTA-Weekly-Evidence-Report-31-July-to-06-August-2021.pdf2024-02-28 09:18 479K 
[ ]HTA-Weekly-Evidence-Report-31-Oct-06-Nov-2020.pdf2024-02-27 10:54 450K 
[IMG]HTA-_-COVID-150x150.png2024-02-13 15:56 8.8K 
[IMG]HTA-_-COVID-300x114.png2024-02-13 15:56 14K 
[IMG]HTA-_-COVID-500x191.png2024-02-13 15:56 25K 
[IMG]HTA-_-COVID-768x293.png2024-02-13 15:56 41K 
[IMG]HTA-_-COVID-1024x391.png2024-02-13 15:56 60K 
[IMG]HTA-_-COVID-1536x586.png2024-02-13 15:56 111K 
[IMG]HTA-_-COVID-2048x781.png2024-02-13 15:56 171K 
[IMG]HTA-_-COVID.png2024-02-13 15:56 3.1M 
[ ]HTAC-Approved-ES_AstraZeneca.pdf2024-02-29 13:56 1.0M 
[ ]HTAC-Evaluation-Framework-for-COVID-19-Vaccines.pdf2024-02-29 10:41 181K 
[ ]HTAC-Evidence-Summary-2nd-Booster-50-and-above-and-18-49-with-comorbidities.pdf2024-02-26 09:54 708K 
[ ]HTAC-Interim-Recommendations-on-Pediatric-Vaccination-for-2022-COVID-19-Vaccine-Implementation-with-Annex.pdf2024-02-29 14:03 862K 
[ ]HTAC-PRESS-RELEASE-25-NOVEMBER-2022-English-Version.pdf2024-02-29 14:55 137K 
[ ]HTAC-PRESS-RELEASE-25-NOVEMBER-2022-Filipino-version.pdf2024-02-29 14:55 137K 
[ ]HTAC-Recommendation-on-Rapid-Antibody-Based-Tests-for-COVID-19_-as-of-01-August-2020.pdf2024-02-27 13:08 6.6M 
[ ]HTAC-pool-of-experts_Department-Personnel-Order-2021-2780-1.pdf2024-02-29 10:35 102K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-150x150.jpg2024-02-26 10:07 4.9K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-300x134.jpg2024-02-26 10:07 9.2K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-500x223.jpg2024-02-26 10:07 23K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-768x343.jpg2024-02-26 10:07 49K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-1024x457.jpg2024-02-26 10:07 75K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-1536x686.jpg2024-02-26 10:07 135K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-2048x914.jpg2024-02-26 10:07 192K 
[IMG]HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357.jpg2024-02-26 10:07 257K 
[IMG]HTACStocktaking_67-150x150.jpg2024-02-13 16:00 9.4K 
[IMG]HTACStocktaking_67-300x157.jpg2024-02-13 16:00 17K 
[IMG]HTACStocktaking_67-500x261.jpg2024-02-13 16:00 39K 
[IMG]HTACStocktaking_67-768x401.jpg2024-02-13 16:00 78K 
[IMG]HTACStocktaking_67-1024x535.jpg2024-02-13 16:00 125K 
[IMG]HTACStocktaking_67-1536x802.jpg2024-02-13 16:00 228K 
[IMG]HTACStocktaking_67.jpg2024-02-13 16:00 510K 
[IMG]IGP-150x150.png2024-02-06 11:35 35K 
[IMG]IGP.png2024-02-06 11:35 107K 
[IMG]Janssen-HCP-150x150.png2024-02-29 17:15 8.8K 
[IMG]Janssen-HCP-300x114.png2024-02-29 17:15 14K 
[IMG]Janssen-HCP-500x191.png2024-02-29 17:15 28K 
[IMG]Janssen-HCP-768x293.png2024-02-29 17:15 47K 
[IMG]Janssen-HCP-1024x390.png2024-02-29 17:15 66K 
[IMG]Janssen-HCP-1536x585.png2024-02-29 17:15 104K 
[IMG]Janssen-HCP-2048x781.png2024-02-29 17:15 144K 
[IMG]Janssen-HCP.png2024-02-29 17:15 194K 
[ ]MEMO-DOH-PROGRAMS-and-PHIC-ON-TOPIC-NOMINATION-DEADLINE.pdf2024-02-29 13:19 135K 
[IMG]MI-PC-Banner-150x150.png2024-02-26 15:48 12K 
[IMG]MI-PC-Banner-300x82.png2024-02-26 15:48 16K 
[IMG]MI-PC-Banner-500x137.png2024-02-26 15:48 34K 
[IMG]MI-PC-Banner-768x210.png2024-02-26 15:48 58K 
[IMG]MI-PC-Banner-1024x280.png2024-02-26 15:48 86K 
[IMG]MI-PC-Banner.png2024-02-26 15:48 42K 
[ ]Memo-on-Minor-Inclusions.pdf2024-02-29 13:23 135K 
[ ]Memo-to-DOH-Internal-Offices-Acknowledgement-of-Comments_Concurrence-on-COVID-19-Vaccines-Evaluation-Framework.pdf2024-02-29 14:05 147K 
[ ]Memo-to-DOH-Internal-Offices-Consultation-for-COVID-19-Vaccines-Evaluation-Framework.pdf2024-02-29 10:14 146K 
[IMG]Minor_Inclusions_-_Banner-150x150.png2024-02-26 10:30 6.8K 
[IMG]Minor_Inclusions_-_Banner-300x82.png2024-02-26 10:30 12K 
[IMG]Minor_Inclusions_-_Banner-500x137.png2024-02-26 10:30 27K 
[IMG]Minor_Inclusions_-_Banner-768x210.png2024-02-26 10:30 45K 
[IMG]Minor_Inclusions_-_Banner-1024x280.png2024-02-26 10:30 67K 
[IMG]Minor_Inclusions_-_Banner.png2024-02-26 10:30 55K 
[IMG]Ms.-Lee-150x150.png2024-02-06 11:35 38K 
[IMG]Ms.-Lee.png2024-02-06 11:35 121K 
[ ]OIC-SOH-Approved-ES-Eribulin-for-mSTS-as-of-May-2022.pdf2024-02-26 10:09 332K 
[ ]PCV-ES-OSEC-approved.pdf2024-02-27 13:23 1.9M 
[ ]PCV-Full-HTA-Report-FINAL-.pdf2024-02-27 13:23 4.1M 
[ ]PHE-COVID-19-MPX-Evidence-Brief-DEC-24-31.pdf2024-02-23 13:30 562K 
[ ]PR-DOH-OFFICIALLY-TRANSFERS-OPERATIONS-OF-HTA-TO-DOST-RECOGNIZING-PARTNERSHIP-AND-NETWORK-FOR-STRENGTHENED-HEALTH-TECHNOLOGY-CAPACITY.pdf2024-02-28 10:59 413K 
[IMG]Picture-DOH-holds-first-HTA-public-consultation-2-150x150.png2024-02-13 15:55 7.5K 
[IMG]Picture-DOH-holds-first-HTA-public-consultation-2-300x170.png2024-02-13 15:55 20K 
[IMG]Picture-DOH-holds-first-HTA-public-consultation-2-500x283.png2024-02-13 15:55 42K 
[IMG]Picture-DOH-holds-first-HTA-public-consultation-2.png2024-02-13 15:55 41K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-150x150.jpg2024-02-13 15:55 6.2K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-300x204.jpg2024-02-13 15:55 14K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-500x339.jpg2024-02-13 15:55 30K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-768x521.jpg2024-02-13 15:55 58K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1.jpg2024-02-13 15:55 95K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-150x150.jpg2024-02-13 16:05 6.2K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-300x204.jpg2024-02-13 16:05 14K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-500x339.jpg2024-02-13 16:05 30K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-768x521.jpg2024-02-13 16:05 58K 
[IMG]Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2.jpg2024-02-13 16:05 95K 
[IMG]PrevProm-Chair-Dr.-Abrogena-150x150.png2024-02-06 13:37 30K 
[IMG]PrevProm-Chair-Dr.-Abrogena.png2024-02-06 13:37 93K 
[ ]RDT_edited-Evidence-Summary.pdf2024-02-27 13:39 301K 
[ ]RR_Favipiravir-Avigan.pdf2024-02-27 13:33 1.6M 
[ ]RR_IgG.IgM-RDT-Kits.pdf2024-02-27 13:39 1.7M 
[ ]RR_MA-Cycloferon.pdf2024-02-27 13:37 1.7M 
[ ]RR_RT-PCR_HTAU.PPE_.03.08.2020_FINAL.pdf2024-02-27 13:26 1.5M 
[ ]SOH-Approved-Evidence-Summary-of-Rituximab-SC-as-of-July-2022-Recommendation.pdf2024-02-26 10:02 74K 
[ ]SOH-Approved-Evidence-Summary-of-Rituximab-SC-as-of-July-2022.pdf2024-02-26 10:01 1.0M 
[IMG]Sambong_250mg_Banner-150x150.png2024-02-26 16:27 10K 
[IMG]Sambong_250mg_Banner-300x82.png2024-02-26 16:27 15K 
[IMG]Sambong_250mg_Banner-500x137.png2024-02-26 16:27 31K 
[IMG]Sambong_250mg_Banner-768x210.png2024-02-26 16:27 52K 
[IMG]Sambong_250mg_Banner-1024x280.png2024-02-26 16:27 75K 
[IMG]Sambong_250mg_Banner.png2024-02-26 16:27 39K 
[ ]Signed-HTAC-Letter-from-Office-of-the-Secretary-on-ECMO-14-September-2020.pdf2024-02-27 13:03 4.1M 
[ ]Signed-by-OSEC-HTAC-Recommendations-on-Booster-and-Additional-Dose.pdf2024-02-29 14:02 1.7M 
[ ]Signed-by-SOH-September-Updates-on-the-2021-HTAC-Recommendations-for-Rapid-Antigen-Testing-merged.pdf2024-02-29 13:50 538K 
[IMG]Sinpharm_HCP_Cover-150x150.png2024-02-29 16:10 34K 
[IMG]Sinpharm_HCP_Cover-300x114.png2024-02-29 16:10 51K 
[IMG]Sinpharm_HCP_Cover-500x191.png2024-02-29 16:10 141K 
[IMG]Sinpharm_HCP_Cover-768x293.png2024-02-29 16:10 328K 
[IMG]Sinpharm_HCP_Cover-1024x390.png2024-02-29 16:10 584K 
[IMG]Sinpharm_HCP_Cover-1536x585.png2024-02-29 16:10 1.3M 
[IMG]Sinpharm_HCP_Cover-2048x781.png2024-02-29 16:10 2.3M 
[IMG]Sinpharm_HCP_Cover.png2024-02-29 16:10 11M 
[ ]Summary-of-Findings-HTAC-Recommendation-on-2nd-booster-for-individuals-ages-185-49-years-old-without-comorbidities.pdf2024-02-29 10:39 30K 
[IMG]Trad-Med-Chair-Dr.-Sia-150x150.png2024-02-06 13:37 30K 
[IMG]Trad-Med-Chair-Dr.-Sia.png2024-02-06 13:37 95K 
[IMG]Vasopressin_-_Banner-150x150.png2024-02-26 16:18 9.4K 
[IMG]Vasopressin_-_Banner-300x82.png2024-02-26 16:18 14K 
[IMG]Vasopressin_-_Banner-500x137.png2024-02-26 16:18 30K 
[IMG]Vasopressin_-_Banner-768x210.png2024-02-26 16:18 51K 
[IMG]Vasopressin_-_Banner-1024x280.png2024-02-26 16:18 76K 
[IMG]Vasopressin_-_Banner.png2024-02-26 16:18 59K 
[ ]Vax-2022-Pedia-ES_For-HTAC.pdf2024-02-29 13:34 1.1M 
[IMG]WEBHC-teaser-photo-150x150.jpg2024-02-13 15:57 7.3K 
[IMG]WEBHC-teaser-photo-300x197.jpg2024-02-13 15:57 15K 
[IMG]WEBHC-teaser-photo-500x328.jpg2024-02-13 15:57 33K 
[IMG]WEBHC-teaser-photo-768x504.jpg2024-02-13 15:57 61K 
[IMG]WEBHC-teaser-photo-1024x673.jpg2024-02-13 15:57 92K 
[IMG]WEBHC-teaser-photo-1536x1009.jpg2024-02-13 15:57 162K 
[IMG]WEBHC-teaser-photo.jpg2024-02-13 15:57 229K 
[IMG]agnette-peralta-150x150.png2024-02-06 11:29 44K 
[IMG]agnette-peralta.png2024-02-06 11:29 144K 
[ ]dc2020-0011_Non-exemption_in_the_PNF.pdf2024-02-29 10:02 101K 
[ ]dm2021-0158-PNF-inlcusion-of-Na-Hyaluronate-and-PD-Solution.pdf2024-02-29 10:56 140K 
[IMG]doc-peng-150x150.png2024-02-06 13:28 30K 
[IMG]doc-peng.png2024-02-06 13:28 89K 
[IMG]dosthtad1-150x150.png2024-02-29 11:01 46K 
[IMG]dosthtad1-300x196.png2024-02-29 11:01 113K 
[IMG]dosthtad1-500x327.png2024-02-29 11:01 293K 
[IMG]dosthtad1-768x502.png2024-02-29 11:01 636K 
[IMG]dosthtad1.png2024-02-29 11:01 735K 
[IMG]dosthtad2-150x150.png2024-02-29 11:01 45K 
[IMG]dosthtad2-300x196.png2024-02-29 11:01 112K 
[IMG]dosthtad2-500x326.png2024-02-29 11:01 291K 
[IMG]dosthtad2-768x501.png2024-02-29 11:01 635K 
[IMG]dosthtad2.png2024-02-29 11:01 1.0M 
[IMG]dosthtad3-150x150.png2024-02-29 11:01 46K 
[IMG]dosthtad3-300x196.png2024-02-29 11:01 108K 
[IMG]dosthtad3-500x326.png2024-02-29 11:01 274K 
[IMG]dosthtad3-768x501.png2024-02-29 11:01 587K 
[IMG]dosthtad3.png2024-02-29 11:01 1.0M 
[IMG]dosthtad4-150x150.png2024-02-29 11:01 43K 
[IMG]dosthtad4-300x196.png2024-02-29 11:01 108K 
[IMG]dosthtad4-500x326.png2024-02-29 11:01 273K 
[IMG]dosthtad4-768x501.png2024-02-29 11:01 579K 
[IMG]dosthtad4.png2024-02-29 11:01 677K 
[IMG]dosthtad5-150x150.png2024-02-29 11:01 54K 
[IMG]dosthtad5-300x159.png2024-02-29 11:01 114K 
[IMG]dosthtad5-500x265.png2024-02-29 11:01 299K 
[IMG]dosthtad5-768x406.png2024-02-29 11:01 656K 
[IMG]dosthtad5.png2024-02-29 11:01 1.1M 
[IMG]dosthtad6-150x150.png2024-02-29 11:01 55K 
[IMG]dosthtad6-300x159.png2024-02-29 11:01 115K 
[IMG]dosthtad6-500x265.png2024-02-29 11:01 301K 
[IMG]dosthtad6-768x406.png2024-02-29 11:01 652K 
[IMG]dosthtad6.png2024-02-29 11:01 1.1M 
[IMG]dosthtad7-150x150.png2024-02-29 11:01 53K 
[IMG]dosthtad7-300x159.png2024-02-29 11:01 109K 
[IMG]dosthtad7-500x265.png2024-02-29 11:01 288K 
[IMG]dosthtad7-768x406.png2024-02-29 11:01 631K 
[IMG]dosthtad7.png2024-02-29 11:01 1.1M 
[IMG]dosthtad9-150x150.png2024-02-29 11:01 45K 
[IMG]dosthtad9-300x225.png2024-02-29 11:01 126K 
[IMG]dosthtad9-500x375.png2024-02-29 11:01 312K 
[IMG]dosthtad9.png2024-02-29 11:01 690K 
[IMG]marita-reyes-150x150.png2024-02-06 13:12 30K 
[IMG]marita-reyes.png2024-02-06 13:12 84K 
[IMG]prof-aleth-150x150.png2024-02-06 13:31 34K 
[IMG]prof-aleth.png2024-02-06 13:31 104K 
[IMG]slider1-1024x512-1-150x150.png2024-02-13 15:53 41K 
[IMG]slider1-1024x512-1-300x150.png2024-02-13 15:53 83K 
[IMG]slider1-1024x512-1-500x250.png2024-02-13 15:53 211K 
[IMG]slider1-1024x512-1-768x384.png2024-02-13 15:53 456K 
[IMG]slider1-1024x512-1.png2024-02-13 15:53 785K 
[ ]v4-01-March23-Dapagliflozin.pdf2024-02-28 11:06 534K 
[IMG]vacant_member-150x150.png2024-02-06 11:26 3.0K 
[IMG]vacant_member.png2024-02-06 11:26 7.4K 
[IMG]viber_image_2022-10-20_10-46-39-238-1-500x375-1-150x150.jpg2024-02-29 09:50 9.5K 
[IMG]viber_image_2022-10-20_10-46-39-238-1-500x375-1-300x225.jpg2024-02-29 09:50 23K 
[IMG]viber_image_2022-10-20_10-46-39-238-1-500x375-1.jpg2024-02-29 09:50 57K 
[IMG]viber_image_2022-12-15_17-59-04-224-500x889-1-150x150.jpg2024-02-13 15:59 7.8K 
[IMG]viber_image_2022-12-15_17-59-04-224-500x889-1-169x300.jpg2024-02-13 15:59 15K 
[IMG]viber_image_2022-12-15_17-59-04-224-500x889-1.jpg2024-02-13 15:59 90K 
Apache/2.4.29 (Ubuntu) Server at hta.dost.gov.ph Port 443